Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: An exploratory analysis of the outcomes of elderly patients in the RECORD-1 trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Molecular Targeted Therapy
  • Protein Kinase Inhibitors
  • Sirolimus
  • TOR Serine-Threonine Kinases

abstract

  • Everolimus is effective and tolerable in elderly patients with mRCC. When selecting targeted therapies in these patients, the specific toxicity profile of each agent and any patient comorbidities should be considered.

publication date

  • April 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4142675

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2011.12.057

PubMed ID

  • 22297244

Additional Document Info

start page

  • 826

end page

  • 33

volume

  • 61

number

  • 4